Post-Market Evaluation of the EVO ICL

NACompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

September 23, 2022

Primary Completion Date

September 21, 2023

Study Completion Date

October 4, 2023

Conditions
MyopiaMyopic Astigmatism
Interventions
DEVICE

EVO ICL

The EVO ICL is intended to be implanted within the posterior chamber, directly behind the iris, and in front of the anterior capsule of the human crystalline lens.

Trial Locations (8)

44141

Cleveland Eye Clinic, Brecksville

57108

Vance Thompson Vision, Sioux Falls

66210

Durrie Vision, Overland Park

68118

Kugler Vision, PC, Omaha

75243

Key-Whitman Eye Center, Dallas

78229

Parkhurst NuVision, San Antonio

84107

The Eye Institute of Utah, Salt Lake City

96814

Aloha Laser Vision, LLC, Honolulu

All Listed Sponsors
lead

Staar Surgical Company

INDUSTRY